AB1419 PERFORMANCE OF AN EARLY TRIAGE SYSTEM FOR IDENTIFICATION OF PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES

Background The preselection of patients with suspicion an inflammatory rheumatic disease is not easy for general practitioners and orthopedists. In countries a limited number practicing rheumatologists waiting lists are often long, since full rheumatologic examination needs long consultation time. Objectives To test the performance early triage strategy identification diseases. Methods Prior to SARS-CoV 2 pandemic, physicians caring contacting tertiary cente were first contacted by health-care professional (HPR) who offered appointment timing which was based on symptoms reported (Step 1). Patients then seen rheumatologist who, within 10-minute 2), shortly examined patient determine urgency planned work up. main outcome study comparison between initial assessment final expert diagnosis 3). Results Within 9 months, 1.180 hospital, 972 whom kept their (82.4%). Most transferred GPs (73.1%) orthopedists (22.1%). mean time Step 1 10.4 days, while 6.2% 4 24.4% 7 days 69.3% 12 weeks. Only 36 (3.7%) had already established disease. Complaints lasting 0-4 weeks 69 (7.1%), > 4-12 100 (10.3%), 973 (82.6%) patients. Almost 90% pain intensity >4/10 (NRS) < An elevated CRP found in 207 (24.5%). treatment glucocorticoids 163 (16.8%) NSAIDs 730 (75.1% of) confirmed at 3 rheumatoid arthritis 127 (13.1%), spondyloarthritis including psoriatic 72 (7.4%), systemic diseases connective tissue 112 (11.5%), vasculitides 41 (4.2%), crystal arthropathy 38 (3.9%) patients, infection, malignancy or differential such as Raynaud’s phenomenon sicca syndrome. Degenerative joint (n=254; 26.1%) non-inflammatory soft syndromes fibromyalgia (n=369; 38%) accounted more than half Conclusion This describes standardized system hereby confirming need musculoskeletal symptoms, involvement HPRs phase contact. Based results, three complaints be order identify one Disclosure Interests None declared